Il progresso e l’aggiornamento sono sempre più mandatori, e l’obiettivo della presente 2a edizione del Treviso Lung Day è sottolineare quanto - ora più che mai - sia importante il confronto scientifico internazionale su alcuni argomenti principali delle malattie respiratorie, come l’asma bronchiale, la BPCO, le malattie polmonari interstiziali diffuse, il tumore del polmone, e - doverosamente in questo anno - la gestione della grave insufficienza respiratoria acuta nella pandemia Covid-19.
It has now been two years since the previous 1st edition of Treviso Lung Day, and more than one year since, on March 11th 2020, the World Health Organization declared the Covid-19 epidemic a global pandemic, something that does not have precedents. Everything
has changed since then. The pandemic has “taught” a lot to us health professionals, and especially to us Pulmonologists who, thanks to our fast professional and organizational response capacity, have played a fundamental role in its health management.
Moreover, without forgetting that during the last year, Pulmonology units have also continued to manage chronic respiratory diseases, sometimes in completely innovative ways.
Progress and updating are increasingly mandatory, and the objective of this 2nd edition of Treviso Lung Day is to underline how important is - now more than ever - the international scientific debate on some main topics of respiratory diseases, such as bronchial asthma, COPD, diffuse interstitial lung disease, lung cancer, and - dutifully this year - the management of severe acute respiratory failure in the Covid-19 pandemic.